Ettore Silvagni

1.6k total citations
49 papers, 816 citations indexed

About

Ettore Silvagni is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Ettore Silvagni has authored 49 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Rheumatology, 18 papers in Immunology and 10 papers in Hematology. Recurrent topics in Ettore Silvagni's work include Systemic Lupus Erythematosus Research (21 papers), Rheumatoid Arthritis Research and Therapies (21 papers) and Autoimmune and Inflammatory Disorders Research (10 papers). Ettore Silvagni is often cited by papers focused on Systemic Lupus Erythematosus Research (21 papers), Rheumatoid Arthritis Research and Therapies (21 papers) and Autoimmune and Inflammatory Disorders Research (10 papers). Ettore Silvagni collaborates with scholars based in Italy, Greece and United Kingdom. Ettore Silvagni's co-authors include Alessandra Bortoluzzi, Marcello Govoni, Carlo Alberto Scirè, Garifallia Sakellariou, Greta Carrara, Massimo Borrelli, Alessandro Giollo, Nicola Ughi, Melissa Padovan and Francesco Trotta and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Ettore Silvagni

46 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ettore Silvagni Italy 17 579 269 128 125 117 49 816
Elena Elefante Italy 19 644 1.1× 312 1.2× 60 0.5× 86 0.7× 141 1.2× 72 1.0k
Laura Massaro Italy 19 768 1.3× 355 1.3× 83 0.6× 125 1.0× 150 1.3× 46 990
Serena Fasano Italy 19 601 1.0× 425 1.6× 72 0.6× 97 0.8× 156 1.3× 45 995
G. Castellino Italy 17 623 1.1× 343 1.3× 165 1.3× 81 0.6× 185 1.6× 32 934
E. K. Li China 18 702 1.2× 427 1.6× 60 0.5× 142 1.1× 65 0.6× 23 934
Xiaomei Leng China 15 408 0.7× 417 1.6× 35 0.3× 75 0.6× 92 0.8× 79 855
Shizuyo Tsujimura Japan 16 539 0.9× 286 1.1× 82 0.6× 87 0.7× 89 0.8× 33 969
Antonio Sánchez United States 6 680 1.2× 249 0.9× 42 0.3× 342 2.7× 90 0.8× 20 1.0k
Larissa Lisnevskaia Canada 6 505 0.9× 394 1.5× 32 0.3× 47 0.4× 111 0.9× 8 738
Viola Signorini Italy 13 487 0.8× 308 1.1× 38 0.3× 47 0.4× 94 0.8× 31 640

Countries citing papers authored by Ettore Silvagni

Since Specialization
Citations

This map shows the geographic impact of Ettore Silvagni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ettore Silvagni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ettore Silvagni more than expected).

Fields of papers citing papers by Ettore Silvagni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ettore Silvagni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ettore Silvagni. The network helps show where Ettore Silvagni may publish in the future.

Co-authorship network of co-authors of Ettore Silvagni

This figure shows the co-authorship network connecting the top 25 collaborators of Ettore Silvagni. A scholar is included among the top collaborators of Ettore Silvagni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ettore Silvagni. Ettore Silvagni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Silvagni, Ettore, Argyro Repa, Konstantinos Parperis, et al.. (2025). Combination of clinical factors predicts successful glucocorticoid withdrawal in systemic lupus erythematosus (SLE): results from a multicentre, retrospective cohort study. RMD Open. 11(1). e005118–e005118. 3 indexed citations
2.
Silvagni, Ettore, Simone Appenzeller, George Βertsias, et al.. (2025). Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study. Lupus Science & Medicine. 12(1). e001490–e001490.
3.
Giovannini, Ivan, Enzo Errichetti, Ettore Silvagni, et al.. (2025). POS0299 RISK ANALYSIS OF CLINICAL PSORIATIC ARTHRITIS DEVELOPMENT IN PATIENTS WITH PSORIASIS AND RECENT-ONSET ARTHRALGIA. Annals of the Rheumatic Diseases. 84. 560–561.
4.
Silvagni, Ettore, Alessandra Bortoluzzi, Giuseppe Bellelli, et al.. (2025). Frailty and cardiovascular safety of JAK inhibitors versus TNF inhibitors in rheumatoid arthritis: a real-world comparative study of drug effects and patient profiles. Frontiers in Pharmacology. 16. 1565909–1565909. 2 indexed citations
6.
Zabotti, Alen, Filippo Fagni, Laure Gossec, et al.. (2024). Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage. RMD Open. 10(2). e004314–e004314. 16 indexed citations
7.
Schiliró, Davide, Ettore Silvagni, Elena Elefante, et al.. (2024). Systemic lupus erythematosus: one year in review 2024. Clinical and Experimental Rheumatology. 42(3). 583–592. 3 indexed citations
8.
Castellazzi, Massimiliano, et al.. (2024). Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review. Diagnostics. 14(3). 242–242. 3 indexed citations
9.
Govoni, Marcello, et al.. (2023). Optimizing Patient Care: A Systematic Review of Multidisciplinary Approaches for SLE Management. Journal of Clinical Medicine. 12(12). 4059–4059. 6 indexed citations
10.
Zucchi, Dina, Ettore Silvagni, Elena Elefante, et al.. (2023). Systemic lupus erythematosus: one year in review 2023. Clinical and Experimental Rheumatology. 41(5). 997–1008. 39 indexed citations
11.
Lanza, Giovanni, Roberta Gafà, Alessandro Borghi, et al.. (2023). Evaluation of the Synovial Effects of Biological and Targeted Synthetic DMARDs in Patients with Psoriatic Arthritis: A Systematic Literature Review and Meta-Analysis. International Journal of Molecular Sciences. 24(5). 5006–5006. 4 indexed citations
12.
Adinolfi, Antonella, Alessandra Bortoluzzi, Georgios Filippou, et al.. (2023). Novel insights into the management of rheumatoid arthritis: one year in review 2023. Clinical and Experimental Rheumatology. 41(11). 2129–2141. 14 indexed citations
13.
Carrara, Greta, Lisa Argnani, Anna Zanetti, et al.. (2022). Persistence of bDMARD therapy in Rheumatoid Arthritis after first-line TNF-inhibitor failure: the RECORD study of the Italian Society for Rheumatology. Scandinavian Journal of Rheumatology. 51(5). 363–367. 2 indexed citations
14.
Silvagni, Ettore, Sara Zandonella Callegher, Annarita Tullio, et al.. (2022). Musculoskeletal ultrasound for treating rheumatoid arthritis to target—a systematic literature review. Lara D. Veeken. 61(12). 4590–4602. 14 indexed citations
15.
Bortoluzzi, Alessandra, et al.. (2022). Focus on Sex and Gender: What We Need to Know in the Management of Rheumatoid Arthritis. Journal of Personalized Medicine. 12(3). 499–499. 58 indexed citations
16.
Marchesoni, Antonio, Pierluigi Macchioni, Stefania Gasparini, et al.. (2021). Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study. Journal of Clinical Medicine. 11(1). 180–180. 8 indexed citations
17.
Silvagni, Ettore, Sonia Missiroli, Mariasole Perrone, et al.. (2021). From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis. Frontiers in Pharmacology. 12. 672515–672515. 23 indexed citations
19.
20.
Govoni, Marcello, Alessandra Bortoluzzi, Melissa Padovan, et al.. (2016). The diagnosis and clinical management of the neuropsychiatric manifestations of lupus. Journal of Autoimmunity. 74. 41–72. 134 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026